Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

Clinical trial NCT02294552 · COMPLETED

Trial details

NCT number: NCT02294552
Sponsor: Ivan S Moiseev
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoid Leukemia Lymphoma Myelodysplastic Syndromes Chronic Lymphocytic Leukemia Immune System Diseases

Start date: 2014-10-01
Primary completion: 2016-11-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.